USAQ (QHSLab) FFO


USAQ QHSLab Inc USAQ
44 GF Score
Price $0.27
GF Value $0.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is QHSLab FFO?

FFO (Funds from operations) only applies to REITs.

USAQ
44GF Score
QHSLab Inc USAQ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is QHSLab (USAQ) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of $0.27 is trading 39.5% above its estimated GF Value™ of $0.19. GuruFocus considers QHSLab to be Significantly Overvalued.

Key valuation signals for USAQ:

  • FFO:
  • GF Value™: $0.19 vs. price of $0.27 (39.5% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the USAQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QHSLab Business Description

Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
44GF Score

Get the complete analysis for USAQ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price
$0.19
GF Value